SARS-CoV-2 & Flu A/B& RSV Combo Antigen Test

This Goldsite SARS-CoV-2, influenza A/B, and RSV combo antigen test is a rapid lateral flow immunoassay for simultaneous screening of three major respiratory viruses. Fifteen-minute turnaround supports emergency departments and outpatient fever clinics in Pakistan where COVID-19, influenza, and RSV symptoms overlap during cold weather months. Kits are available as 1 test per kit or 25 tests per kit from Goldsite, China. Product documentation notes SARS-CoV-2 as a triggered virus target and positions the assay within Goldsite’s COVID-19 line. Specimen type and procedural steps are defined in the manufacturer instructions; train collectors on correct swab technique to avoid invalid runs. Combo testing can reduce sequential single-analyte kits when ward stock is limited. Interpret results as qualitative screening alongside clinical findings and local epidemiology. Supply is available through Zymotic Diagnostics International as part of the Goldsite infectious disease rapid test range.